Compare American Well Corp (AMWL) vs YieldMax Magnificent 7 Fund of Option Income ETFs (YMAG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs YieldMax Magnificent 7 Fund of Option Income ETFs — how do they compare? American Well Corp trades at $10.54 (market cap $165.58M), while YieldMax Magnificent 7 Fund of Option Income ETFs trades at $11.73. The key difference: American Well Corp is trading nearer its 52-week high, YieldMax Magnificent 7 Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.
| AMWL | YMAG | |
|---|---|---|
Market Cap | $165.58M | — |
Sector | Health | Income / Options Overlay |
52-Week High | $9.91 | $15.98 |
52-Week Low | $3.78 | $11.00 |
Enterprise Value | -$9.66M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
YMAG trades at $11.81 with a 1.2% daily gain, showing modest momentum amid bearish technical signals. The ETF's weekly dividend strategy provides income but faces headwinds from its overall bearish technical rating and mixed oscillators. Recent news highlights YieldMax's consistent distribution announcements, though analyst coverage remains limited for this specialized fund-of-ETFs product.
The outlook remains cautious given the bearish technical setup and structural concerns about NAV decay in option-income strategies. While weekly distributions offer income appeal, the fund's performance depends heavily on volatility monetization capabilities during rangebound markets. Key risks include expense ratio drag and underperformance during strong bull markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG is an actively managed 'fund of funds' that provides equal-weighted exposure to the seven YieldMax ETFs tracking the 'Magnificent 7' tech giants (Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla). It seeks to generate high current income by harvesting option premiums across these leaders, offering a streamlined way to access concentrated tech volatility in an income-producing format.
Read more on YMAG →
